abim
Addressing and Improving ABIM LKA Knowledge Gaps
The ABIM LKA is a continuous learning tool that can help physicians stay current and refine their skills.
Brugada type 1 ECG plus syncope is high risk. Learn why ICD—not Holter or observation—is the board-relevant next step per major guidelines.
When syncope occurs with a type 1 Brugada ECG pattern, the board-relevant next step is sudden-death prevention with an implantable cardioverter-defibrillator (ICD), not outpatient monitoring.
Question – Next step after syncopal event
A 45-year-old man with a history of hypertension and diabetes mellitus presents to you for evaluation after a syncopal event earlier today. He is currently with no symptoms and notes no focal weakness or numbness. He takes hydrochlorothiazide for hypertension.
His blood pressure is 120/80 mm Hg and his pulse is 83 beats per minute. Findings on general physical and neurologic examinations are normal. Results from a complete blood count and basic metabolic panel are normal. A cardiac marker test is negative. Electrocardiography (ECG) is obtained (see Figure).
Figure.
What would be the best next step in the management of this patient's condition?
Answer Options:
- A. implantation of a cardioverter defibrillator
- B. observation
- C. echocardiography
- D. Holter monitor
This is a classic “ECG pattern + syncope” question. The provided remediation indicates the ECG demonstrates a Brugada type 1 pattern (coved ST-segment elevation in V1–V3 with subsequent T-wave inversion). In major guidelines (ESC 2022; ACC/AHA/HRS 2017), Brugada syndrome becomes high-stakes when paired with clinical events consistent with malignant ventricular arrhythmia—especially syncope that is unexplained and concerning for arrhythmic etiology. In that setting, the exam-reliable next step is ICD placement for prevention of sudden cardiac death.
Why this is frequently missed on boards: many test-takers treat “syncope” as a workup problem (Holter, echo, observation). But Brugada is fundamentally a sudden-death risk problem once symptomatic; monitoring may document arrhythmias but does not mitigate risk. Guidelines consistently emphasize ICD for secondary prevention and for symptomatic Brugada with arrhythmic syncope when the ECG pattern is type 1 and spontaneous/suggestive.
Guideline anchor:
- ESC Ventricular Arrhythmias/SCD Prevention (2022): supports ICD in Brugada patients with prior cardiac arrest/VT and in those with syncope likely arrhythmic plus a spontaneous type 1 pattern (risk-based recommendation).
- ACC/AHA/HRS Ventricular Arrhythmias Guideline (2017): similarly supports ICD therapy in high-risk Brugada presentations (notably syncope presumed arrhythmic with diagnostic ECG pattern), while discouraging ICD in isolated ECG pattern without symptoms.
Why This Family Medicine Question Is Frequently Missed
- It tests whether you recognize Brugada + syncope = high-risk, not “benign syncope workup.”
- Learners overuse Holter/observation when an inherited channelopathy is already suggested on ECG.
- Confusion between Brugada ECG pattern (may be incidental) vs Brugada syndrome (pattern + clinical criteria such as syncope).
What the Distractors Indicate
| Option | What It Tests / Implies | Why It’s Wrong Here |
|---|---|---|
| implantation of a cardioverter defibrillator | Definitive SCD prevention in high-risk channelopathy | Correct: symptomatic Brugada (type 1 pattern + syncope concerning for arrhythmia) warrants ICD per major guidance. |
| observation | Low-risk syncope/benign ECG | Misses potentially lethal ventricular arrhythmia risk in Brugada syndrome. |
| echocardiography | Structural heart disease evaluation | Brugada is primarily an electrical/channelopathy diagnosis; echo may be adjunctive but is not the best “next step” for risk mitigation. |
| Holter monitor | Ambulatory rhythm documentation | May fail to capture intermittent polymorphic VT/VF and does not prevent SCD; not the best next step in a high-risk Brugada presentation. |
High-Yield Pearl for Family Medicine Exam Prep
In type 1 Brugada pattern with syncope suspicious for arrhythmia, choose CD over outpatient monitoring.
Core Learning Objectives
- Recognize the type 1 Brugada ECG pattern and distinguish Brugada syndrome (pattern + clinical criteria) from an incidental Brugada pattern.
- Select ICD therapy as the board-standard management for symptomatic/high-risk Brugada presentations.
The “Test Trick” at Play
The stem distracts you with normal vitals, normal labs, and negative troponin to prompt a “reassurance/monitoring” reflex. Boards reward pattern recognition: when the ECG suggests Brugada and the patient has syncope compatible with arrhythmia, the next step is sudden death prevention, not incremental diagnostics.
Additional FM Practice Questions and Remediation for Brugada Syndrome
Family Medicine Practice Question 1 - “Incidental pattern”
A 38-year-old man is found to have a Brugada-like ECG pattern during a pre-op evaluation. He has never had syncope, seizures, or palpitations. No family history of sudden death. What is the most appropriate management?
- A. Immediate ICD placement
- B. Avoid fever triggers/medication review and arrange cardiology follow-up
- C. Thrombolysis
- D. Start metoprolol
- E. Emergent coronary angiography
Family Medicine Practice Question 2 - “Fever unmasking”
A 29-year-old man develops fever from influenza and has an ECG showing coved ST elevation in V1–V2 consistent with type 1 Brugada pattern. He reports near-syncope while febrile but is now stable. Best immediate step?
- A. Discharge with reassurance only
- B. Start digoxin
- C. Aggressive antipyresis and urgent electrophysiology/cardiology evaluation
- D. High-dose IV beta-blocker
- E. Diltiazem infusion
Family Medicine Practice Question 3 - “True high-risk”
A 46-year-old man with spontaneous type 1 Brugada ECG survives an out-of-hospital cardiac arrest with documented VF. Next step for secondary prevention?
- A. ICD implantation
- B. Holter monitor for 30 days
- C. Aspirin and statin therapy only
- D. Coronary calcium scoring
- E. Carotid duplex ultrasound
Family Medicine Practice Question 4 - “Syncope differential”
A 52-year-old woman has syncope after prolonged standing in a hot room, with prodrome (nausea, diaphoresis). ECG normal. Best next step?
- A. ICD implantation
- B. Reassurance and vasovagal syncope counseling
- C. Emergency EP study
- D. Amiodarone initiation
- E. Implantable loop recorder immediately for all patients
Family Medicine Practice Question 5 - “Brugada vs MI mimic”
A 41-year-old man has coved ST elevation in V1–V2 with negative T waves. He is afebrile, chest-pain free, and troponin is negative. He had unexplained syncope while watching TV. Most appropriate management plan?
- A. Treat as anterior STEMI with immediate thrombolysis
- B. Discharge with outpatient echocardiogram only
- C. Refer for urgent cardiology/EP evaluation; ICD is likely indicated if Brugada type 1 with arrhythmic syncope is confirmed
- D. Start heparin drip and observe for NSTEMI
- E. Start verapamil
Mini Case Discussion Prompt
How would your management change between (1) an incidental Brugada pattern found on ECG, (2) type 1 pattern with fever only, and (3) type 1 pattern with unexplained syncope?
Mini-FAQ
- Q1: What makes Brugada “syndrome” rather than just a Brugada ECG pattern?*
A: Boards expect you to pair a diagnostic ECG (typically type 1) with clinical criteria such as syncope or documented VT/VF—this shifts management toward SCD prevention.
- Q2: Why isn’t a Holter monitor the best next step after syncope with Brugada ECG?*
A: ABIM/board-style questions treat symptomatic Brugada as a malignant ventricular arrhythmia risk; Holter may miss intermittent VF/PMVT and doesn’t prevent sudden death.
- Q3: When is an ICD clearly indicated in Brugada?*
A: After cardiac arrest/VT/VF (secondary prevention) and in high-risk symptomatic patients (e.g., syncope likely arrhythmic with spontaneous type 1 pattern), consistent with ACC/AHA/HRS 2017 and ESC 2022 risk-based guidance.
- Q4: What common trigger should you treat aggressively in suspected Brugada?*
A: Fever—test writers frequently use febrile illness to unmask type 1 pattern; prompt antipyresis and escalation are expected.
Find this and other Family Medicine exam prep questions in Med-Challenger Family Medicine Review with CME
Try for free and save. Ace your exams and meet your CME/MOC requirements for just $35 a month!
No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.
For personal medical education that includes board's prep, MOC, and CME requirements, Med-Challenger has you covered in Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, OBGYN, Physician Assistants, and Nurse Practitioners.
Never miss a thing. Subscribe to our blog and save!
